464. Structural Vulnerability among Patients with HIV and SARS-CoV-2 Coinfection: Descriptive Case Series from the U.S. Midwest
Sign Up to like & getrecommendations! Published in 2021 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofab466.663
Abstract: Abstract Background It is well known that the HIV epidemic and COVID-19 pandemic have both disproportionately harmed marginalized minority and immigrant communities in the United States. The risk factors associated with disease incidence and outcomes… read more here.
Keywords: hiv sars; sars cov; cov coinfection; hiv clinic ... See more keywords
Aspergillus-SARS-CoV-2 Coinfection: What Is Known?
Sign Up to like & getrecommendations! Published in 2022 at "Pathogens"
DOI: 10.3390/pathogens11111227
Abstract: COVID-19-associated pulmonary aspergillosis (CAPA) has had a high incidence. In addition, it has been associated with prolonged hospital stays, as well as several predisposing risk factors, such as fungal factors (nosocomial organism, the size of… read more here.
Keywords: aspergillus sars; addition; coinfection; cov coinfection ... See more keywords
T Cell Response to SARS-CoV-2 Coinfection and Comorbidities
Sign Up to like & getrecommendations! Published in 2023 at "Pathogens"
DOI: 10.3390/pathogens12020321
Abstract: For the past three years, COVID-19 has become an increasing global health issue. Adaptive immune cells, especially T cells, have been extensively investigated in regard to SARS-CoV-2 infection. However, human health and T cell responses… read more here.
Keywords: cell response; cell; sars cov; cov coinfection ... See more keywords